Skip to content
wua. Poland
English

Semaglutide in pregnancy: sheep study finds reduced uterine blood flow, not a proven human risk

AI-generated editorial illustration; this is not a photograph of the event.
Produced by wua.life

A study in pregnant sheep found short-term reductions in maternal cardiac output, uterine blood flow and fetal oxygen levels after semaglutide was administered. It is a research signal worth attention, but it does not establish that the same effect occurs in human pregnancy.

Researchers at the University of Adelaide used MRI to assess the pregnant animals’ heart function and blood flow through the uterus before and after treatment. They also collected fetal blood samples and monitored fetal blood pressure and heart rate. According to Nauka w Polsce, the amount of blood pumped by the animals’ hearts fell significantly within two hours of dosing, alongside reduced blood flow to the uterus and lower fetal oxygen levels.

The finding matters because semaglutide is used to treat type 2 diabetes and obesity, including in Ozempic and Wegovy. Some people may not realise they are pregnant immediately and may therefore remain on treatment for a period after conception. But the reported experiment does not answer whether the short-term changes affect fetal growth, what longer exposure would do, or whether the same mechanism operates in people.

Professor Janna Morrison, one of the study authors, described the results as preliminary. That limitation is central, not incidental: an observation in sheep is a reason for further research, not a clinical finding about pregnant people.

The source says semaglutide is not currently recommended during pregnancy and should be stopped at least two months before a planned conception. Someone who discovers a pregnancy while taking it should not make an independent treatment change on the basis of this animal study alone. The relevant next step is a prompt discussion with the clinician managing their pregnancy, diabetes or weight treatment about their individual circumstances and treatment options.

Sources

Independent editorial content. WUA is not affiliated with any political party. 2026-11-18